Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's After-Market Session

Author: Benzinga Insights | February 19, 2024 05:30pm

Gainers

  • Trxade Health (NASDAQ:MEDS) stock rose 105.3% to $8.5 during Monday's after-market session. The company's market cap stands at $10.2 million.
  • Iovance Biotherapeutics (NASDAQ:IOVA) shares moved upwards by 32.78% to $12.15. The company's market cap stands at $3.1 billion.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) shares moved upwards by 13.29% to $0.37. The company's market cap stands at $4.3 million.
  • Delcath Systems (NASDAQ:DCTH) shares increased by 9.92% to $4.84. The market value of their outstanding shares is at $106.6 million.
  • Dyadic International (NASDAQ:DYAI) shares moved upwards by 9.84% to $1.45. The company's market cap stands at $41.7 million.
  • NexImmune (NASDAQ:NEXI) stock increased by 8.9% to $8.56. The company's market cap stands at $11.1 million.

Losers

  • Universe Pharmaceuticals (NASDAQ:UPC) stock decreased by 27.6% to $1.78 during Monday's after-market session. The market value of their outstanding shares is at $6.4 million.
  • Sientra (NASDAQ:SIEN) stock decreased by 15.9% to $0.26. The market value of their outstanding shares is at $3.0 million.
  • Femasys (NASDAQ:FEMY) stock declined by 12.0% to $1.1. The company's market cap stands at $23.8 million.
  • Nexalin Technology (NASDAQ:NXL) stock decreased by 7.86% to $0.34. The market value of their outstanding shares is at $2.4 million.
  • Orgenesis (NASDAQ:ORGS) stock declined by 7.61% to $0.37. The company's market cap stands at $11.8 million.
  • Lucid Diagnostics (NASDAQ:LUCD) stock declined by 7.36% to $1.26. The company's market cap stands at $54.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: DCTH DYAI FEMY IOVA LUCD MEDS NEXI NXL ORGS SIEN UPC VRPX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist